Issue 123 • October 2022

Nanorobots: small solutions to big delivery problems

Brazil: an untapped market for big pharma manufacturing

Foreign investments amplify the nucleic acid therapeutics field

In association with

Exploring the promise of billion-dollar KRAS drugs

KRAS mutations are one of the most prevalent drivers of cancer, yet they were long considered ‘undruggable’; a new wave of drugs is changing that

09/21/2022 13:15:06